Grilinctus

Company: Franco-Indian Pharmaceuticals Ltd.

Generic Drug: Terbutaline Sulphate + Bromhexine.

Indication: Productive cough associated with bronchitis, bronchial asthma, chronic obstructive pulmonary disease (COPD), bronchiectasis, emphysema and other broncho-spastic disorders.

Contraindication: Hypersensitivity to any of the component in the preparation.

Dosage & Administration: Available as syrup, to be used as directed by physician.

Children (2-6 yrs) : 1/2 – 1 tsp. thrice daily.
Children (6-14 yrs) : 1 – 2 tsp. thrice daily.

Special Precautions: Cautious use is recommended in patients with hepatic impairment, renal impairment, chronic lung disease, cardiac failure, hypertension, high fever, hyperthyroidism, arrhythmias, pulmonary edema, diabetes mellitus, convulsive disorders and history of peptic ulcers.

Side effects/ Undesired effects/ Adverse drug reactions: Common adverse events are tremors, headache, anorexia, muscle cramps, palpitations, nausea, irritability, insomnia, heartburn, gastritis, anxiety, nervousness, and central nervous disturbances. Behavioral disturbances may occur.

This entry was posted in Asthma Medications and tagged . Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *